Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

ClinicalTrials.gov ID: NCT04770220

Public ClinicalTrials.gov record NCT04770220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype

Study identification

NCT ID
NCT04770220
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Alzheon Inc.
Industry
Enrollment
325 participants

Conditions and interventions

Interventions

  • Experimental: ALZ-801 Drug
  • Placebo Comparator: Placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 18, 2021
Primary completion
May 28, 2024
Completion
Jul 28, 2024
Last update posted
Nov 9, 2025

2021 – 2024

United States locations

U.S. sites
55
U.S. states
21
U.S. cities
53
Facility City State ZIP Site status
Xenoscience Phoenix Arizona 85004
CCT Research Scottsdale Arizona 85297
Banner Sun Health Research Institute Sun City Arizona 85351
ATP Clinical Research Costa Mesa California 92626
Tilda Research Irvine California 92780
UCSD Shiley-Marcos Alzheimer's Disease Research Center La Jolla California 92037
Torrance Clinical Research Institute Lomita California 90717
Collaborative NeuroScience Network LLC Long Beach California 90806
Stanford University Palo Alto California 94304
SC3 Research Group Pasadena California 91105
Sutter Health Sacramento California 95816
JEM Research Institute, Headlands Site Atlantis Florida 33462
Bradenton Research Center Bradenton Florida 34205
Galiz Research Hialeah Florida 33016
Alphab Global Research Jupiter Florida 33458
Charter Research Lady Lake Florida 32159
K2 Medical Research, LLC Maitland Florida 32751
Miami Jewish Health Miami Florida 33137
Y & L Advance Health Care, Inc /DBA Elite Clinical Research Miami Florida 33144
Mount Sinai Medical Center Miami Beach Florida 33140
Aqualane Clinical Research Naples Florida 34105
Charter Research Orlando Florida 32803
Headlands Research Orlando Orlando Florida 32819
Advanced Research Consultants Palm Beach Gardens Florida 33410
Quantum CNS Clinical Research Pompano Beach Florida 33064
Progressive Medical Research Port Orange Florida 32127
ALZ Research and Treatment Center (A.R.T.C.) Stuart Florida 34997
ALZ Research and Treatment Center (A.R.T.C.) Wellington Florida 33414
Premiere Research Institute West Palm Beach Florida 33407
Columbus Memory Center Columbus Georgia 31909
Sandhill Research, LLC Decatur Georgia 30030
Fort Wayne Neurological Center Fort Wayne Indiana 46804
Louisiana State University Health Sciences Center (LSUHSC) Shreveport Louisiana 71103
Headlands Research Eastern MA Plymouth Massachusetts 02360
WR-CRCN Las Vegas Nevada 89106
Advanced Memory Research Center Toms River New Jersey 08755
Neurological Associates of Albany Albany New York 12208
NYU Alzheimer's Disease Research Center New York New York 10016
Kline Institute for Psychiatric Research Orangeburg New York 10962
University of Rochester Medical Center Rochester New York 14620
Richmond Behavioral Associates Staten Island New York 10312
Triad Clinical Trials Greensboro North Carolina 27410
AMC Research Matthews North Carolina 28105
NeuroScience Research Center Canton Ohio 44718
Neurology Diagnostics, Inc. Dayton Ohio 45459
IPS Research Oklahoma City Oklahoma 73106
Center for Cognitive Health Portland Oregon 97225
Abington Neurological Associates Abington Pennsylvania 19001
Lehigh Center for Clinical Research Allentown Pennsylvania 18104
Rhode Island Mood & Memory Research Institute East Providence Rhode Island 02914
Vanderbilt Center for Cognitive Medicine Nashville Tennessee 37212
UT Health Science Center at Houston Houston Texas 77054
Re:Cognition Health Fairfax Virginia 22031
Northwest Clinical Research Center Bellevue Washington 98007
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04770220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 9, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04770220 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →